VYNE - VYNE Therapeutics Inc
0.6018
0.012 1.928%
Share volume: 114,333
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.59
0.01
0.02%
Summary score
37%
Profitability
43%
Dept financing
23%
Liquidity
58%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2021 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.07%
Return on assets
-17.88%
Return on sales
-14587.2%
Return on invested capital
130.65%
Total debt ratio
20.02%
Debt ratio change over timeo
-0.83%
Current Ratio
6.13%
Quick Ratio
6.18%
Cash Position Ratio
4.44%
Short-term ratios 30-Jun-2024 - 30-Jun-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-15.35%
Return on sales
-10228.6%
Return on invested capital
0%
Total debt ratio
18.99%
Debt ratio change over timeo
0%
Current Ratio
5.47%
Quick Ratio
0%
Cash Position Ratio
2.47%
Last quarter ratios 30-Jun-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.85%
Return on sales
-10930.43%
Return on invested capital
0%
Total debt ratio
13.05%
Debt ratio change over time
0%
Current Ratio
7.6%
Quick Ratio
0%
Cash Position Ratio
3.78%
Performance ratios (change over 4 years) 30-Jun-2021 - 30-Jun-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-119.33%
Return on assets
-114.56%
Return on sales
-7663.76%
Return on invested capital
-33.17%
Total debt ratio
-83.09%
Debt ratio change over time
-0.83%
Current Ratio
3.37%
Quick Ratio
3.08%
Cash Position Ratio
2.51%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VYNE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -25.07% | 13.37% | 9.26% | 24.74% |
| Return on assets | -17.88% | 4.46% | 3.19% | 1.96% |
| Return on sales | -14587.2% | 29.32% | 25.1% | 26.16% |
| Return on invested capital | 130.65% | 8.27% | 9.6% | 4.15% |
| Profitability | 25% | 65% | 50% | 59% |
| Total debt ratio | 20.02% | 80.99% | 59.51% | 92.59% |
| Debt ratio change over time | -0.83% | -13.82% | -64.56% | 51.48% |
| Dept financing | 5% | 22% | 16% | 50% |
| Current Ratio | 5.47% | 1.27% | 1.1% | 0.7% |
| Quick Ratio | 0% | 0.98% | 0.86% | 0.59% |
| Cash Position Ratio | 2.47% | 0.11% | 0.47% | 0.15% |
| Liquididy | 75% | 9% | 12% | 8% |
| Short-term ratios | VYNE | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -15.35% | 4.77% | 3.56% | 0.99% |
| Return on sales | -10228.6% | 31.14% | 23.64% | 19.08% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 38% | 21% |
| Total debt ratio | 18.99% | 81.85% | 60.01% | 98.11% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 30% | 21% | 15% | 25% |
| Current Ratio | 5.47% | 1.27% | 1.1% | 0.7% |
| Quick Ratio | 0% | 0.98% | 0.86% | 0.59% |
| Cash Position Ratio | 2.47% | 0.11% | 0.47% | 0.15% |
| Liquididy | 50% | 32% | 32% | 20% |